dsp 4 has been researched along with Atherosclerotic Parkinsonism in 4 studies
DSP 4: RN given refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Chen, X | 1 |
| Wang, T | 1 |
| Sun, YN | 1 |
| Han, LN | 1 |
| Li, LB | 1 |
| Zhang, L | 1 |
| Wu, ZH | 1 |
| Huang, C | 1 |
| Liu, J | 1 |
| Delaville, C | 1 |
| Navailles, S | 1 |
| Benazzouz, A | 1 |
| Pérez, V | 1 |
| Sosti, V | 1 |
| Rubio, A | 1 |
| Barbanoj, M | 1 |
| Rodríguez-Alvarez, J | 1 |
| Kulisevsky, J | 1 |
| Nishi, K | 1 |
| Kondo, T | 1 |
| Narabayashi, H | 1 |
1 review available for dsp 4 and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
[A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzylamines; Dopamine; Levodopa; Locomotion; | 1987 |
3 other studies available for dsp 4 and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Additional noradrenergic depletion aggravates forelimb akinesia and abnormal subthalamic nucleus activity in a rat model of Parkinson's disease.
Topics: Action Potentials; Animals; Benzylamines; Disease Models, Animal; Dopamine; Forelimb; Male; Norepine | 2014 |
Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
Topics: Animals; Benzylamines; Electrophysiological Phenomena; Extracellular Space; Fenclonine; Globus Palli | 2012 |
Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antip | 2007 |